State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF vs Tenet Healthcare Corporation — how do they compare? State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF trades at $30.8, while Tenet Healthcare Corporation trades at $199.06 (market cap $16.57B). The key difference: State Street SPDR Bloomberg Invstmt Gr Fltg Rt ETF is trading nearer its 52-week high, Tenet Healthcare Corporation nearer its low. Which is the better fit depends on your goals.
| FLRN | THC | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $30.86 | $244.80 |
52-Week Low | $30.65 | $148.38 |
Market Cap | — | $16.57B |
Enterprise Value | — | $26.81B |
Signals from Pluang's Aura AI — not financial advice
FLRN trades at $30.79 with no price movement in the last 24 hours. The technical picture shows a bearish trend with moving averages indicating selling pressure, though oscillators are neutral. Key financial ratios including P/E, P/S, and ROE are unavailable in the current data. Recent corporate actions include three dividend payments of $0.11 each scheduled for mid-2026, suggesting management's commitment to shareholder returns despite the current technical weakness.
The outlook for FLRN appears cautious with bearish technical signals dominating. The stock faces headwinds from the current market environment where inflation concerns are driving investors toward inflation-protected assets. Investment opportunities exist in the consistent dividend payments, but risks include the overall bearish technical setup and potential pressure from rising interest rates that could impact stock valuations broadly.
Tenet Healthcare (THC) trades at $198.46, up 8.04% in the last 24 hours, showing strong momentum. The stock is supported by a bullish analyst consensus with a $235.88 price target, while recent earnings have consistently beaten expectations. However, technical indicators signal a bearish short-term trend, with the price currently testing key support levels near $191.
The outlook is positive based on solid fundamentals, including a low P/E of 10 and strong profitability metrics like a 37.87% ROE. Key risks include market volatility ahead of Q2 2026 earnings on July 24 and potential macroeconomic pressures on the healthcare sector. The primary opportunity lies in the stock's attractive valuation relative to its growth and analyst targets.
Trailing returns across standard periods
FLRN invests in U.S. dollar-denominated investment-grade floating rate notes with maturities under five years. It provides exposure to corporate and supranational debt whose interest payments adjust with market rates, helping to mitigate interest rate risk.
Read more on FLRN →Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →